Select Page
Investors

Investors

Successful IPO of MEDESIS PHARMA, a biotechnology pharmaceutical company, on Euronext Growth Paris® (ISIN: FR0010844464, MNEMO: ALMDP). Visit the Investors section for more information
Become shareholders

Become shareholders

Medesis Pharma is planning an introduction to the stock market in the years 2018/2019. Capital increases are made each year to finance all research and development. To invest in the capital of our company, please use the contact section of the site
Financing history: an atypical financing of the company

Financing history: an atypical financing of the company

All capital contributions were exclusively made by private individuals. The company currently has 190 shareholders. We are mainly relying on capital infusions from our shareholders with a cumulated amount of €21 million injected in the Company capital over the last 14...